Margarite Matosssian, MD, PhD, presents exciting data showing new therapeutic approaches that target metastatic sites using kinase inhibitors along with chemotherapy in triple negative breast cancer. #AACR26
@MargariteMatos1

@UChicagoHemOnc

@UChicagoBreast